{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:10:20Z","timestamp":1791274220481,"version":"4.1.0"},"reference-count":90,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health and Fondazione Roma"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220435","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T17:30:12Z","timestamp":1564162212000},"page":"e0220435","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Neuroenhancement and neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: A randomized pilot study"],"prefix":"10.1371","volume":"14","author":[{"given":"Vincenzo","family":"Parisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Barbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Renzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8510-6925","authenticated-orcid":true,"given":"Gianluca","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5563-1243","authenticated-orcid":true,"given":"Lucia","family":"Ziccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,7,26]]},"reference":[{"issue":"R2","key":"ref1","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1093\/hmg\/ddx273","article-title":"Optic neuropathies: the tip of the neurodegeneration iceberg","volume":"26","author":"V Carelli","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/MN:26:1:045","article-title":"Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection","volume":"26","author":"MB Wax","year":"2002","journal-title":"Mol Neurobiol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/18715273113126660189","article-title":"Necroptosis: who knew there were so many interesting ways to die?","volume":"13","author":"SM Fayaz","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5483\/BMBRep.2018.51.5.074","article-title":"The role of necroptosis in the treatment of diseases","volume":"51","author":"YS Cho","year":"2018","journal-title":"BMB Rep"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1167\/iovs.12-9483i","article-title":"The cell and molecular biology of glaucoma: axonopathy and the brain","volume":"53","author":"DJ Calkins","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1167\/iovs.14-14525","article-title":"Nerve fiber layer thinning lags retinal ganglion cell density following crush axonopathy","volume":"55","author":"GC Munguba","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"e85718","DOI":"10.1371\/journal.pone.0085718","article-title":"Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis","volume":"9","author":"JG Yu","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"e0134750","DOI":"10.1371\/journal.pone.0134750","article-title":"Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis","volume":"10","author":"G Coppola","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/archopht.123.11.1554","article-title":"Visual field abnormalities in non-arteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination","volume":"123","author":"SS Hayreh","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5858\/arpa.2016-0027-RS","article-title":"Pathology of Ischemic Optic Neuropathy","volume":"141","author":"HR Patel","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1468-1331.2008.02200.x","article-title":"Electrophysiological assessment of visual function in patients with non-arteritic ischaemic optic neuropathy","volume":"15","author":"V Parisi","year":"2008","journal-title":"Eur J Neurol"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/WNO.0000000000000521","article-title":"Structure-Function Analysis of Nonarteritic Anterior Ischemic Optic Neuropathy and Age-Related Differences in Outcome","volume":"37","author":"MH Sun","year":"2017","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/WNO.0000000000000493","article-title":"Optical coherence tomography angiography in nonarteritic anterior ischemic optic neuropathy","volume":"37","author":"E Wright Mayes","year":"2017","journal-title":"J Neuroophthalmol"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00417-017-3774-y","article-title":"Optical coherence tomography angiography in acute arteritic and non-arteritic anterior ischemic optic neuropathy","volume":"255","author":"N Balducci","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.ophtha.2007.05.042","article-title":"Follow-up of nonarteritic anterior ischemic optic neuropathy with optical coherence tomography","volume":"114","author":"I Contreras","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10072-014-1982-3","article-title":"Acute optic neuritis: retinal ganglion cell loss precedes retinal nerve fiber thinning","volume":"36","author":"YM Huang-Link","year":"2015","journal-title":"Neurol Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jns.2016.12.044","article-title":"Majid AMSA, Majid ASA, Tamayol A. Ischemic optic neuropathy as a model of neurodegenerative disorder: A review of pathogenic mechanism of axonal degeneration and the role of neuroprotection","volume":"375","author":"S Khalilpour","year":"2017","journal-title":"J Neurol Sci"},{"issue":"4","key":"ref18","first-page":"585","article-title":"Neuroprotection and regeneration in glaucoma","volume":"18","author":"LA Levin","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ophtha.2011.11.003","article-title":"Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement","volume":"119","author":"EE Chang","year":"2012","journal-title":"Ophthalmology"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1442-9071.2011.02563.x","article-title":"Translational neuroprotection research in glaucoma: a review of definitions and principles","volume":"40","author":"RJ Casson","year":"2012","journal-title":"Clin Exp Ophthalmol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-398309-1.00002-0","article-title":"Optic nerve disease and axon pathophysiology","volume":"105","author":"A Ghaffarieh","year":"2012","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"ref22","first-page":"171","article-title":"Regeneration of functional synaptic connections between widely separated neurons in the adult mammalian central nervous system","volume":"85","author":"M. Rasminsky","year":"1991","journal-title":"J Physiol (Paris)"},{"issue":"1261","key":"ref23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1098\/rstb.1991.0025","article-title":"Degenerative and regenerative responses of injured neurons in the central nervous system of adult mammals","volume":"331","author":"AJ Aguayo","year":"1991","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"055001","DOI":"10.1088\/1741-2560\/6\/5\/055001","article-title":"Electrical activity enhances neuronal survival and regeneration","volume":"6","author":"RG Corredor","year":"2009","journal-title":"J Neural Eng"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00347-016-0264-2","article-title":"Immunomodulation and neuroprotection in optic neuritis","volume":"113","author":"F Beisse","year":"2016","journal-title":"Ophthalmologe"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/1352458516642315","article-title":"A prospective cohort study of vitamin D in optic neuritis recovery","volume":"23","author":"JM Burton","year":"2017","journal-title":"Mult Scler"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jamaneurol.2018.0024","article-title":"Effect of treating acute optic neuritis with bioequivalent oral vs intravenous corticosteroids: a randomized clinical trial","volume":"75","author":"SA Morrow","year":"2018","journal-title":"JAMA Neurol"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.17116\/jnevro201711710144-48","article-title":"The efficacy of recognan in the early stage of ischemic stroke","volume":"117","author":"VV Mashin","year":"2017","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"S03","key":"ref29","first-page":"S1","article-title":"Citicoline: pharmacological and clinical review, 2016 update","volume":"63","author":"JJ Secades","journal-title":"Rev Neurol. 2016"},{"issue":"4","key":"ref30","first-page":"86","article-title":",","volume":"117","author":"DV Sergeev","year":"2017","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0253-7613.201037","article-title":"Is aura around citicoline fading? A systemic review","volume":"49","author":"S Agarwal","year":"2017","journal-title":"Indian J Pharmacol"},{"issue":"6","key":"ref32","first-page":"664","article-title":"Clinical trial on the use of cytidine diphosphate choline in Parkinson's disease","volume":"10","author":"JM Cubells","year":"1988","journal-title":"Clin Ther"},{"issue":"5","key":"ref33","first-page":"718","article-title":"Effects of citicholine in subcortical dementia associated with Parkinson's disease assessed by quantified electroencephalography","volume":"14","author":"A Garc\u00eda-Mas","year":"1992","journal-title":"Clin Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1749-6632.1996.tb34452.x","article-title":"Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors","volume":"777","author":"R Cacabelos","year":"1996","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1358\/mf.1999.21.9.795632","article-title":"Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion","volume":"21","author":"XA Alvarez","year":"1999","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0161-6420(99)90269-5","article-title":"Cytidine-5'-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma","volume":"106","author":"V Parisi","year":"1999","journal-title":"Ophthalmology"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10633-005-7348-7","article-title":"Electrophysiological assessment of glaucomatous visual dysfunction during treatment with Cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up","volume":"110","author":"V. Parisi","year":"2005","journal-title":"Doc Ophthalmol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0079-6123(08)01137-0","article-title":"Evidence of the neuroprotective role of citicoline in glaucoma patients","volume":"173","author":"V Parisi","year":"2008","journal-title":"Prog Brain Res"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00417-015-3044-9","article-title":"Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma","volume":"253","author":"V Parisi","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4103\/0301-4738.133484","article-title":"A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy","volume":"62","author":"G Roberti","year":"2014","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1468-1331.2008.02099.x","article-title":"Cytidine-5\u2032 -diphosphocholine (citicoline): a pilot study in patients with nonarteritic ischaemic optic neuropathy","volume":"15","author":"V Parisi","year":"2008","journal-title":"Eur J Neurol"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.eye.6701588","article-title":"Optic nerve and neuroprotection strategies","volume":"18","author":"NN Osborne","year":"2004","journal-title":"Eye (Lond)"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.exer.2005.02.007","article-title":"Neuroprotective effect of citicoline against KA-induced neurotoxicity in the rat retina","volume":"81","author":"CH Park","year":"2005","journal-title":"Exp Eye Res"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.exer.2006.05.021","article-title":"Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat","volume":"83","author":"F Schuettauf","year":"2006","journal-title":"Exp Eye Res"},{"issue":"7","key":"ref45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/1570159X15666170703111729","article-title":"Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function","volume":"16","author":"V Parisi","year":"2018","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.17116\/jnevro20181181118-22","article-title":"The study of the membrane-protective potential of the combination of 2-ethyl-6-methyl-3-hydroxypyridine-succinate and citicoline","volume":"118","author":"EY Solovyeva","year":"2018","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"8","key":"ref47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1472-8206.1993.tb01041.x","article-title":"Dopaminergic modulation of visual sensitivity in man","volume":"7","author":"G Masson","year":"1993","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000063658","article-title":"Citicoline treatment increases retinal dopamine content in rabbits","volume":"34","author":"R Rejdak","year":"2002","journal-title":"Ophthalmic Res"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/B:DOOP.0000019487.88486.0a","article-title":"Dopamine and retinal function","volume":"108","author":"P Witkovsky","year":"2004","journal-title":"Doc Ophthalmol"},{"issue":"12","key":"ref50","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1111\/j.1460-9568.2005.04512.x","article-title":"Dopamine regulates melanopsin mRNA expression in intrinsically photosensitive retinal ganglion cells","volume":"22","author":"K Sakamoto","year":"2005","journal-title":"Eur J Neurosci"},{"key":"ref51","first-page":"1049","article-title":"Routes of administration and serum levels of [Methyl-14C]-Cytidine-Diphosphocholine","volume":"34","author":"A Roda","year":"1983","journal-title":"Curr Ther Res"},{"issue":"7A","key":"ref52","first-page":"1045","article-title":"Bioavailability of methyl-14C CDP-choline by oral route","volume":"33","author":"J Agut","year":"1983","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000350496","article-title":"Citicoline oral solution in glaucoma: is there a role in slowing disease progression?","volume":"229","author":"L Ottobelli","year":"2013","journal-title":"Ophthalmologica"},{"issue":"9","key":"ref54","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0161-6420(01)00649-2","article-title":"Optic disc morphology after arteritic anterior ischemic optic neuropathy","volume":"108","author":"SS Hayreh","year":"2001","journal-title":"Ophthalmology"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.icu.0000188361.52166.93","article-title":"Nonarteritic anterior ischemic optic neuropathy","volume":"16","author":"MK Mathews","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"ref56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00417-005-0102-8","article-title":"Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial","volume":"244","author":"B Wilhelm","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/IJG.0b013e318279b836","article-title":"Effects of coenzyme Q10 in conjunction with vitamin E on retinal-evoked and cortical-evoked responses in patients with open-angle glaucoma","volume":"23","author":"V Parisi","year":"2014","journal-title":"J Glaucoma"},{"issue":"5","key":"ref58","first-page":"726","article-title":"Pattern ERGs and visual evoked potentials in maculopathies and optic nerve diseases","volume":"26","author":"GG Celesia","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"ref59","first-page":"310","article-title":"Effect of decreased retinal illumination on simultaneously recorded pattern electroretinograms and visual evoked potentials","volume":"32","author":"JE Froehlich","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/IJG.0b013e318279b836","article-title":"Effects of Coenzyme Q10 in conjunction with vitamin E on retinal-evoked and cortical-evoked responses in patients with open-angle glaucoma","volume":"23","author":"V Parisi","year":"2014","journal-title":"J Glaucoma"},{"issue":"10","key":"ref61","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1167\/iovs.10-5412","article-title":"Electrophysiological detection of delayed post-retinal neural conduction in human amblyopia","volume":"51","author":"V Parisi","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-016-9553-y","article-title":"ISCEV standard for clinical visual evoked potentials\u2013(2016 update)","volume":"133","author":"JV Odom","year":"2016","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0013-4694(70)90007-6","article-title":"Evoked cortical responses to checkerboard patterns: effect of check-size as a function of visual acuity","volume":"28","author":"MR Harter","year":"1970","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00004691-198401000-00003","article-title":"Evoked potential techniques in the evaluation of visual function","volume":"1","author":"GG Celesia","year":"1984","journal-title":"J Clin Neurophysiolol"},{"issue":"8","key":"ref65","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s004170050289","article-title":"Predictive value of pattern VEP, pattern ERG and hole size in macular hole surgery","volume":"237","author":"MA Tilanus","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"ref66","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1167\/iovs.13-12894","article-title":"Retinal function and neural conduction along the visual pathways in affected and unaffected carriers with Leber's hereditary optic neuropathy","volume":"54","author":"L Ziccardi","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"ref67","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00417-015-2979-1","article-title":"Multifocal VEP provide electrophysiological evidence of predominant dysfunction of the optic nerve fibers derived from the central retina in Leber's hereditary optic neuropathy","volume":"253","author":"L Ziccardi","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"ref68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-012-9353-y","article-title":"ISCEV standard for clinical pattern electroretinography (PERG)","volume":"126","author":"M Bach","year":"2013","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"ref69","first-page":"41","article-title":"Visual evoked potentials and ultrasonography in ischemic optic neuropathy","volume":"53","author":"M. Varga","year":"2002","journal-title":"Oftalmologia"},{"issue":"10","key":"ref70","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1167\/iovs.03-0274","article-title":"Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy","volume":"44","author":"SL Bernstein","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"ref71","first-page":"CD000269","article-title":"Cytidinediphosphocholine (CDPcholine) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev","author":"M Fioravanti","year":"2005"},{"issue":"2","key":"ref72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1076\/ceyr.17.2.141.5606","article-title":"Cytidine-5'-diphosphocholine improves visual acuity, contrast sensitivity and visually-evoked potentials of amblyopic subjects","volume":"17","author":"V Porciatti","year":"1998","journal-title":"Curr Eye Res"},{"issue":"1","key":"ref73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00417-007-0621-6","article-title":"Effect of oral CDP-choline on visual function in young amblyopic patients","volume":"246","author":"M Fresina","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"ref74","first-page":"489","article-title":"Citicoline in the treatment of Parkinson's disease","volume":"12","author":"R Eberhardt","year":"1990","journal-title":"Clin Ther"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/JEP.S63544","article-title":"Current knowledge on the neuroprotective and neuroregenerative properties of citicoline in acute ischemic stroke","volume":"7","author":"MY Martynov","year":"2015","journal-title":"J Exp Pharmacol"},{"issue":"3","key":"ref76","first-page":"173","article-title":"Probably role of citicoline in stroke rehabilitation: review of the literature","volume":"54","author":"JJ Secades","year":"2012","journal-title":"Rev Neurol"},{"issue":"3","key":"ref77","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1515\/cclm-2012-0559","article-title":"Choline-containing phospholipids: relevance to brain functional pathways","volume":"51","author":"SK Tayebati","year":"2013","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"ref78","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00417-008-0767-x","article-title":"Retinal nerve fiber layer thickness in nonarteritic anterior ischemic optic neuropathy: OCT characterization of the acute and resolving phases","volume":"246","author":"C Bellusci","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/WNO.0000000000000345","article-title":"Retinal Ganglion Cell Loss Precedes Retinal Nerve Fiber Thinning in Nonarteritic Anterior Ischemic Optic Neuropathy","volume":"36","author":"M Akbari","year":"2016","journal-title":"J Neuroophthalmol"},{"issue":"8","key":"ref80","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1167\/iovs.15-18736","article-title":"Retinal ganglion cell layer thinning within one month of presentation for non-arteritic anterior ischemic optic neuropathy","volume":"57","author":"MJ Kupersmith","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2147\/OPTH.S42522","article-title":"Long-term retinal nerve fiber layer changes following nonarteritic anterior ischemic optic neuropathy","volume":"7","author":"G Dotan","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"ref82","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3109\/02713683.2015.1084640","article-title":"Change of Retinal Nerve Layer Thickness in Non-Arteritic Anterior Ischemic Optic Neuropathy Revealed by Fourier Domain Optical Coherence Tomography","volume":"41","author":"M Han","year":"2016","journal-title":"Curr Eye Res"},{"issue":"4","key":"ref83","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.3390\/ijms15046286","article-title":"Neuroprotective effects of citicoline in in vitro models of retinal neurodegeneration","volume":"15","author":"A Matteucci","year":"2014","journal-title":"Int J Mol Sci"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12974\/2309-6136.2015.03.01.1","article-title":"In vivo evaluation of retinal and choroidal structure in a mouse model of long-lasting diabetes. Effect of topical treatment with citicoline","volume":"3","author":"S Maestroni","year":"2015","journal-title":"J Ocul Dis Ther"},{"issue":"1","key":"ref85","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41598-018-36473-2","article-title":"In vivo effects of single or combined topical neuroprotective and regenerative agents on degeneration of retinal ganglion cells in rat optic nerve crush model","volume":"9","author":"Y Kitamura","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"ref86","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/STROKEAHA.112.654806","article-title":"Citicoline enhances neuroregenerative processes after experimental stroke in rats","volume":"43","author":"K Diederich","year":"2012","journal-title":"Stroke"},{"issue":"16","key":"ref87","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/00001756-200211150-00023","article-title":"Citicoline has a protective effect on damaged retinal ganglion cells in mouse culture retina","volume":"13","author":"T Oshitari","year":"2002","journal-title":"Neuroreport"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2010.05.073","article-title":"Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose","volume":"1346","author":"T Oshitari","year":"2010","journal-title":"Brain Res"},{"issue":"8","key":"ref89","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1111\/aos.13128","article-title":"Distinguishing ischaemic optic neuropathy from optic neuritis by ganglion cell analysis","volume":"94","author":"N Erlich-Malona","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"ref90","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00417-015-3230-9","article-title":"Early macular ganglion cell-inner plexiform layer analysis in non- arteritic anterior ischemic optic neuropathy","volume":"254","author":"SW Park","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0221313","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0220435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T11:51:38Z","timestamp":1721562698000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220435"}},"subtitle":[],"editor":[{"given":"Luciano","family":"Quaranta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,26]]},"references-count":90,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220435","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0221313","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,26]]}}}